DexCom (DXCM) PT Lowered to $62 at BMO Capital
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.88 +0.31%
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
32 Buy, 7 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
BMO Capital lowered its price target on DexCom (NASDAQ: DXCM) to $62.00 (from $90.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna (KLAR) PT Lowered to $15 at BMO Capital
- BofA Securities Upgrades Moderna (MRNA) to Neutral
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
